New Virulent Strain of MRSA Resistant to Vancomycin
The recent meeting of the Infectious Diseases Society of America featured a study from the Henry Ford Health System in Detroit assessing a new strain of methicillin-resistant Staphylococcus aureus (MRSA). The strain, called USA600, is associated with poorer outcomes than other strains of MRSA and is associated with vancomycin resistance—the drug primarily used to treat MRSA.
According to the study, the strain typically appears in older, sicker patients with comorbidities and frequently occurs in nursing homes. Mortality in patients with USA600 was 50% in the study, although overall incidence was low and didn’t seem to grow over the past three years.
While this particular strain, in the scheme of all things MRSA, might not be of great concern now, remember that other strains of MRSA were once primarily a healthcare-associated infection, but community-acquired MRSA is now common.
Has your lab seen the MRSA USA600 strain yet? What strains do you see most frequently?